newsfilter
← Latest News
PR Newswire·

AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...